Literature DB >> 17278228

Analysis of immune responses against H pylori in rabbits.

Khademul Islam1, Ibrahim Khalil, Chowdhury Rafiqul Ahsan, Mahmuda Yasmin, Jamalun Nessa.   

Abstract

AIM: To investigate the immunogenicity of H pylori proteins, to evaluate the production rate of anti H pylori IgG antibodies in relation to time and to demonstrate the fidelity of newly optimized in-house enzyme-linked immunosorbent assay (ELISA) technique as an alternative for H pylori infection assay.
METHODS: In the present study, 100 microg of formalin-fixed H pylori whole cell antigens was injected into an experimental animal (New Zealand white female rabbit) intramuscularly on d 0, 16, 27 and 36. The first two doses were injected with adjuvants. On d 0, a serum sample was collected from the rabbit before immunization and this pre-immunized serum was used as a negative control for the whole study. To evaluate the immunogenic responses of the injected antigen, serum samples were collected from the rabbit at regular intervals up to d 42. The sera were analyzed using in-house ELISA and Western blot techniques.
RESULTS: The production of anti H pylori IgG antibodies in the rabbit in response to the injected antigen increased almost exponentially up to d 14 and after that it was maintained at the same level until the last day (d 42). By analyzing the immune profiles of immunized sera, 11 proteins were identified to be immunogenic, among them 2 (approximately 100 kDa and 85 kDa) were most prominent.
CONCLUSION: Analysis of the immune responses against pathogenic microorganisms like H pylori is necessary for the development of various diagnostic and preventive approaches. The results of this experiment reveal that the formalin-fixed H pylori whole cell antigens injected into the rabbit are highly immunogenic. These prominent proteins (approximately 100 kDa and 85 kDa) might have higher immunogenic effects among humans infected with H pylori and some of these immunogenic proteins can be included in diagnostic approaches based on serology and also for vaccine formulation. The in-house ELISA is a promising alternative compared to invasive techniques.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17278228      PMCID: PMC4065984          DOI: 10.3748/wjg.v13.i4.600

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  29 in total

1.  Triple, standard quadruple and ampicillin-sulbactam-based quadruple therapies for H. pylori eradication: a comparative three-armed randomized clinical trial.

Authors:  Seyed Amir Mirbagheri; Mehrdad Hasibi; Mehdi Abouzari; Armin Rashidi
Journal:  World J Gastroenterol       Date:  2006-08-14       Impact factor: 5.742

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 3.  Immunoblotting and dot immunobinding--current status and outlook.

Authors:  H Towbin; J Gordon
Journal:  J Immunol Methods       Date:  1984-09-04       Impact factor: 2.303

Review 4.  Helicobacter pylori and the pathogenesis of gastroduodenal inflammation.

Authors:  M J Blaser
Journal:  J Infect Dis       Date:  1990-04       Impact factor: 5.226

5.  Antigen profile of Helicobacter pylori strains isolated from peptic ulcer patients in Dhaka, Bangladesh.

Authors:  M Haque; K M Rahman; A K Khan; M Hassan; M R Miah; F Qadri; Q Akhter
Journal:  Bangladesh Med Res Counc Bull       Date:  1993-12

6.  Soluble surface proteins from Helicobacter pylori activate monocytes/macrophages by lipopolysaccharide-independent mechanism.

Authors:  U E Mai; G I Perez-Perez; L M Wahl; S M Wahl; M J Blaser; P D Smith
Journal:  J Clin Invest       Date:  1991-03       Impact factor: 14.808

7.  Interferon gamma and interleukin 4 secreting cells in the gastric antrum in Helicobacter pylori positive and negative gastritis.

Authors:  R Karttunen; T Karttunen; H P Ekre; T T MacDonald
Journal:  Gut       Date:  1995-03       Impact factor: 23.059

8.  Comparison of different criteria for interpretation of immunoglobulin G immunoblotting results for diagnosis of Helicobacter pylori infection.

Authors:  Philipp M Lepper; Angelika Möricke; Konstanze Vogt; Günter Bode; Matthias Trautmann
Journal:  Clin Diagn Lab Immunol       Date:  2004-05

9.  The GroES homolog of Helicobacter pylori confers protective immunity against mucosal infection in mice.

Authors:  R L Ferrero; J M Thiberge; I Kansau; N Wuscher; M Huerre; A Labigne
Journal:  Proc Natl Acad Sci U S A       Date:  1995-07-03       Impact factor: 11.205

10.  Parenteral adjuvant activities of Escherichia coli heat-labile toxin and its B subunit for immunization of mice against gastric Helicobacter pylori infection.

Authors:  R Weltzin; B Guy; W D Thomas; P J Giannasca; T P Monath
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

View more
  4 in total

1.  Analysis of Different Prognostic Indicators for Malnutrition and Shigella flexneri Infection Among the Children in Bangladesh.

Authors:  M Murshida Mahbub; Chowdhury Rafiqul Ahsan; Mahmuda Yasmin; Jamalun Nessa
Journal:  Indian J Microbiol       Date:  2012-03-31       Impact factor: 2.461

2.  Development of an in-house enzyme-linked immunosorbent assay based on surface whole cell antigen for diagnosis of Helicobacter pylori infection in patients with gastroduodenal ulcer disease.

Authors:  Faisal Aziz; Sikander Khan Sherwani; Syed Shakeel Akhtar; Shahana Urooj Kazmi
Journal:  World J Microbiol Biotechnol       Date:  2013-08-07       Impact factor: 3.312

3.  Diversity in the protein N-glycosylation pathways within the Campylobacter genus.

Authors:  Harald Nothaft; Nichollas E Scott; Evgeny Vinogradov; Xin Liu; Rui Hu; Bernadette Beadle; Christopher Fodor; William G Miller; Jianjun Li; Stuart J Cordwell; Christine M Szymanski
Journal:  Mol Cell Proteomics       Date:  2012-08-02       Impact factor: 5.911

4.  Engineering the Campylobacter jejuni N-glycan to create an effective chicken vaccine.

Authors:  Harald Nothaft; Brandi Davis; Yee Ying Lock; Maria Elisa Perez-Munoz; Evgeny Vinogradov; Jens Walter; Colin Coros; Christine M Szymanski
Journal:  Sci Rep       Date:  2016-05-25       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.